Cathie Wood Says AI Innovation’s Biggest Underrated Play Is Healthcare

Ark Invest founder Cathie Wood said in an interview that the most undervalued area of AI innovation is healthcare. She pointed to AI-driven diagnostics that could detect cancer through blood tests before symptoms appear. Wood also highlighted a “patent cliff” in pharma: over the next five years, the industry faces roughly $300 billion in lost value as key drug patents expire and revenues/profits tied to exclusivity drop sharply. She argued that the fear and caution around these upcoming disruptions also creates opportunities for investors. Context for crypto traders: while this is not a direct token- or exchange-related development, it can influence broader risk sentiment toward tech and healthcare equities and the investment flows that sometimes correlate with high-beta crypto phases (e.g., during periods when “AI + innovation” narratives dominate). Traders may watch for whether AI/biotech-related equity strength (or weakness) spills into market-wide appetite for risk, including crypto. Bottom line: AI innovation is framed as a catalyst for earlier cancer detection, and pharma’s patent cliff is framed as both a threat and an opportunity—signals that could affect sector sentiment rather than immediate coin fundamentals.